The Maternal Lineage X-SV DNA Test, available at DNA Labs UAE for a cost of 4800 AED, is a sophisticated genetic analysis designed to trace an individual's maternal ancestry by examining specific segments of DNA passed down from mother to child. This test focuses on the mitochondrial DNA (mtDNA), which is inherited solely from the mother, allowing for the exploration of one's maternal lineage. The X-SV markers in the DNA provide detailed insights into the maternal line, including geographical and ethnic origins, as well as connections to ancient maternal ancestors. Conducted in the state-of-the-art facilities of DNA Labs UAE, this test offers individuals a unique opportunity to uncover their maternal heritage and understand their deep-rooted connections to the past.
Alpha Thalassemia Gene Analysis HBA1 – HBA2 Test is a specialized diagnostic procedure aimed at detecting mutations in the HBA1 and HBA2 genes, which are crucial for the production of the alpha globin component of hemoglobin. Hemoglobin is a protein in red blood cells responsible for transporting oxygen throughout the body. Mutations in these genes can lead to alpha thalassemia, a blood disorder that reduces the production of normal hemoglobin, leading to anemia and other related health issues.
The test is performed by collecting a blood sample from the patient, which is then analyzed using advanced genetic testing techniques to identify any abnormalities or mutations in the HBA1 and HBA2 genes. This test is particularly important for individuals with a family history of thalassemia or those belonging to ethnic groups with a higher prevalence of the disease, as it can help in early diagnosis and management of the condition.
Offered by DNA Labs UAE, the Alpha Thalassemia Gene Analysis HBA1 – HBA2 Test is priced at 4800 AED. DNA Labs UAE is known for its state-of-the-art facilities and expert team of geneticists and medical professionals who ensure accurate and reliable test results. The test is an essential tool in the management and treatment planning of alpha thalassemia, providing vital information for affected individuals and their families.
The Infliximab Antibody Test is a specialized diagnostic procedure designed to measure the levels of infliximab, a therapeutic monoclonal antibody, and antibodies against infliximab in the blood. Infliximab is commonly used in the treatment of autoimmune diseases such as rheumatoid arthritis, Crohn's disease, and ulcerative colitis, helping to reduce inflammation and halt disease progression. However, over time, some patients may develop antibodies against infliximab, reducing the treatment's effectiveness and necessitating adjustments to the therapeutic regimen.
This test is crucial for healthcare providers to determine the presence of these antibodies and to assess the levels of infliximab in the bloodstream, ensuring that patients receive the most appropriate and effective treatment. Conducted at DNA Labs UAE, a leading facility known for its advanced diagnostic services, the Infliximab Antibody Test offers patients and physicians valuable insights into the management of autoimmune conditions. The cost of the test is set at 3900 AED, reflecting the sophisticated nature of the analysis and the high level of accuracy it provides in guiding treatment decisions.
The Infliximab Anti-TNF Blocker Test is a specialized medical examination designed to monitor the levels of the medication Infliximab in a patient's bloodstream. Infliximab is a type of medication known as an anti-TNF (tumor necrosis factor) blocker, which is commonly used to treat various autoimmune diseases, such as rheumatoid arthritis, Crohn's disease, and psoriasis, by reducing inflammation and halting disease progression. This test is particularly crucial for patients undergoing treatment with Infliximab, as it helps healthcare providers to adjust dosages accurately, ensuring the medication's effectiveness while minimizing potential side effects.
The test is conducted at DNA Labs UAE, a reputable laboratory known for its advanced medical testing services. With a focus on precision and reliability, DNA Labs UAE employs state-of-the-art technology and methodologies to ensure accurate results. The cost of the Infliximab Anti-TNF Blocker Test at DNA Labs UAE is 5310 AED, reflecting the sophisticated nature of the examination and the specialized expertise required to interpret its results. By undergoing this test, patients and their healthcare providers can make informed decisions regarding the continuation, adjustment, or cessation of Infliximab therapy, optimizing treatment outcomes and enhancing the quality of life for those affected by chronic autoimmune conditions.
The Growth Hormone Releasing Hormone (GHRH) test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to assess the function of the pituitary gland by measuring its ability to secrete growth hormone in response to stimulation by GHRH. This test is crucial for diagnosing conditions related to growth hormone deficiencies or excesses, such as dwarfism, gigantism, or acromegaly. It involves administering synthetic GHRH to stimulate the pituitary gland and then measuring the levels of growth hormone released into the bloodstream. The cost of the GHRH test at DNA Labs UAE is 5310 AED. This test is particularly important for individuals exhibiting symptoms of growth hormone imbalance, as it helps in formulating an accurate diagnosis and guiding subsequent treatment plans.
The HLA Single Antigen Bead Assay for Class I IgG Antibodies, commonly referred to as the DSA-SAB Class I Test, is a highly specialized laboratory procedure designed to detect and identify specific donor-specific antibodies (DSAs) against Class I HLA antigens. These antibodies can play a significant role in the rejection of transplanted organs and are crucial markers for assessing the compatibility between organ donors and recipients. The test employs a sophisticated technique that uses microbeads coated with purified HLA antigens to accurately identify the presence and specificity of IgG antibodies targeting HLA Class I molecules.
Conducted at DNA Labs UAE, this test is pivotal for patients undergoing or considering organ transplantation, as the presence of DSAs can significantly affect the outcome and longevity of the transplant. By identifying these antibodies, healthcare providers can make informed decisions about donor selection, immunosuppressive therapy, and post-transplant management to improve transplant success rates and patient outcomes.
The cost of the DSA-SAB Class I Test at DNA Labs UAE is 5150 AED. This investment in testing is crucial for ensuring the best possible match between donor and recipient, thereby enhancing the chances of transplant success and long-term health benefits for patients requiring organ transplants.
The Oncopro BRAF Rapid Test is a cutting-edge diagnostic tool designed to identify mutations in the BRAF gene, which are implicated in various forms of cancer, including melanoma, colorectal cancer, and thyroid cancer. This test is particularly significant for guiding the treatment plan for patients, as BRAF mutations can influence the response to specific targeted therapies.
Performed at DNA Labs UAE, a leading facility in genetic testing and personalized medicine, the Oncopro BRAF Rapid Test employs advanced molecular techniques to ensure accurate and swift results. The test is priced at 5150 AED, reflecting the sophisticated technology and expertise involved in its execution.
By opting for this test, patients and healthcare providers can make informed decisions regarding the most effective treatment strategies, potentially improving outcomes and quality of life for those affected by BRAF-mutant cancers.
The Chromosomal Microarray (CMA) 750K High Resolution Test is a cutting-edge genetic test offered by DNA Labs UAE, designed to detect chromosomal abnormalities with unparalleled precision. This test examines the entire genome at a high resolution of 750,000 markers, allowing for the identification of microdeletions and duplications that traditional karyotyping methods might miss. These anomalies can be linked to a wide range of genetic disorders and developmental delays, making this test a valuable tool for early diagnosis and intervention.
With a cost of 2500 AED, the CMA 750K High Resolution Test is an investment in obtaining a comprehensive genetic overview, which can be particularly beneficial for individuals with unexplained developmental issues, autism, intellectual disabilities, or congenital anomalies. Conducted at the state-of-the-art facilities of DNA Labs UAE, this test requires a simple blood sample from which DNA is extracted and analyzed. The results provide detailed insights into one's chromosomal health, offering a roadmap for personalized medical management and informed family planning decisions.
The "CNGA3 Gene Achromatopsia Type 2 Genetic Test" is a specialized diagnostic tool designed to detect mutations in the CNGA3 gene, which are responsible for Achromatopsia Type 2, a rare genetic disorder affecting vision. This condition is characterized by partial or total absence of color vision, light sensitivity, involuntary eye movements, and significantly reduced visual acuity. The test is crucial for accurate diagnosis, enabling personalized management and genetic counseling for affected individuals and their families. Performed at DNA Labs UAE, a leading facility in genetic diagnostics, the test offers reliable results, leveraging advanced genomic technologies. The cost for undergoing this genetic test is 3600 AED, reflecting the comprehensive analysis and expert interpretation that accompanies this service.
The CNGB3 gene achromatopsia type 3 genetic test is a specialized diagnostic tool designed to identify mutations in the CNGB3 gene, which are known to cause achromatopsia type 3. Achromatopsia is a rare, inherited eye condition characterized by partial or total absence of color vision, light sensitivity, and reduced visual acuity. This condition results from mutations in several genes, including CNGB3, which plays a critical role in the normal functioning of cone cells in the retina responsible for color vision.
The test involves collecting a DNA sample, typically through a blood draw or cheek swab, and analyzing it for specific genetic alterations in the CNGB3 gene. Identifying these mutations can confirm a diagnosis of achromatopsia type 3, allowing for appropriate management and genetic counseling for affected individuals and their families.
This genetic test is available at DNA Labs UAE, a leading provider of genetic testing services in the United Arab Emirates. The cost of the CNGB3 gene achromatopsia type 3 genetic test is 4400 AED. This investment in genetic testing can be crucial for families seeking answers about this condition, as it not only aids in diagnosis but also helps in understanding the inheritance pattern, potential risks to other family members, and considerations for future pregnancies.
